Half-year report · Q2
4530.TEDINET S100UIMD
Period2024-03-01 → 2024-08-31
Filed2024-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥75.5bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥141.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥67.0bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Operating income | ¥9.0bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥8.4bn | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | ¥10.8bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.6bn | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥13.1bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥11.6bn | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.1bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥14.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.4bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.4bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥350.5bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥328.8bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥344.3bn | at 2023-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥74.5bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥61.7bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥275.9bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥267.1bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥275.1bn | at 2023-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥113.6bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥112.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash & equivalents | ¥68.6bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥66.4bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥81.2bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.4bn | at 2023-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥8.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥18.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.9bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥4.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥10.4bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥12.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥16.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥122.71 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.62 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.34 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥122.55 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥181.42 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥108.23 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 78.0% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.2% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Filing date cover page | FilingDateInstant | 2024-10-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第123期中(自 2024年３月１日 至 2024年８月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)久光製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | HISAMITSU PHARMACEUTICAL CO.,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 中 冨 一 榮 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)佐賀県鳥栖市田代大官町408番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)0942(83)2101(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員BU本部長 舛 屋 泰 之 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区丸の内二丁目４番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(5293)1700(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員経営企画本部長 磯 部 雄 一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00944 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45300 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)久光製薬株式会社 | |
| Filer name in english | FilingDateInstant | Hisamitsu Pharmaceutical Co.,Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-03-01 | |
| Current period end date | FilingDateInstant | 2024-08-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-02-28 | |
| Previous fiscal year start date | FilingDateInstant | 2023-03-01 | |
| Comparative period end date | FilingDateInstant | 2023-08-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-02-29 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(プライム市場)名古屋証券取引所(プレミア市場)福岡証券取引所 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式(単元株式数は100株) | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |